Literature DB >> 21999865

Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.

Erberto Carluccio1, Paolo Biagioli, Gianfranco Alunni, Adriano Murrone, Paola Pantano, Emilia Biscottini, Cinzia Zuchi, Gianluca Zingarini, Claudio Cavallini, Giuseppe Ambrosio.   

Abstract

OBJECTIVES: The aim of this study was to evaluate whether, in patients with evidence of both electrical and mechanical left ventricular (LV) dyssynchrony, extensive LV dilation would affect response to cardiac resynchronization therapy (CRT).
BACKGROUND: Cardiac resynchronization therapy is effective in heart failure patients with LV dysfunction and wide QRS complex. However, many patients still fail to respond. We hypothesized that presence of extensive LV dilation might prevent response to CRT, despite LV mechanical dyssynchrony.
METHODS: We studied 78 heart failure patients (68 ± 9 years of age, 77% men) with both electrical (QRS width >120 ms) and mechanical intraventricular dyssynchrony (by tissue Doppler imaging and/or left lateral wall post-systolic contraction). Echocardiographic evaluation was performed at baseline and 6 to 8 months after CRT. As an indication of LV remodeling, end-diastolic volume index and end-systolic volume index (ESVI) and sphericity index were measured. Long-term (40 ± 23 months) clinical follow-up (events: cardiac death and hospital admission for heart failure) was also obtained.
RESULTS: At follow-up after CRT, in the overall population, ejection fraction increased from 26 ± 6% to 35 ± 11% (p < 0.0001), whereas end-diastolic volume index (from 144 ± 43 ml/m(2) to 119 ± 55 ml/m(2)), ESVI (from 108 ± 37 ml/m(2) to 82 ± 49 ml/m(2), p < 0.0001 for both), and sphericity index (from 0.60 ± 0.22 to 0.53 ± 0.15, p = 0.0036) all significantly decreased. By multiple linear regression analysis, after controlling for confounding factors, change in LV ejection fraction at follow-up resulted independently and negatively associated with baseline ESVI (p = 0.001), with much lower improvement after implant in the highest tertile of baseline ESVI. During follow-up, 31 patients (39.7%) had a cardiac event. By Cox regression model, baseline ESVI was the most powerful predictor of events, with event-rate/year increasing with increasing tertiles of ESVI (6.3%, 10.1%, and 23.8%, respectively, p < 0.05).
CONCLUSIONS: In this nonrandomized, open-label clinical study, despite intraventricular electrical and mechanical dyssynchrony, extensive LV remodeling at baseline negatively impacted CRT results in terms of LV function improvement and incidence of cardiac events at follow-up.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21999865     DOI: 10.1016/j.jcmg.2011.07.006

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  6 in total

Review 1.  Effects of SGLT2 inhibitors on cardiac structure and function.

Authors:  Giuseppina Novo; Tommaso Guarino; Daniela Di Lisi; Paolo Biagioli; Erberto Carluccio
Journal:  Heart Fail Rev       Date:  2022-06-16       Impact factor: 4.214

2.  Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction.

Authors:  Robert E Michler; Jean L Rouleau; Hussein R Al-Khalidi; Robert O Bonow; Patricia A Pellikka; Gerald M Pohost; Thomas A Holly; Jae K Oh; Francois Dagenais; Carmelo Milano; Krzysztof Wrobel; Jan Pirk; Imtiaz S Ali; Robert H Jones; Eric J Velazquez; Kerry L Lee; Marisa Di Donato
Journal:  J Thorac Cardiovasc Surg       Date:  2012-10-27       Impact factor: 5.209

3.  Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.

Authors:  Niraj Varma; Peter Sogaard; Jeroen J Bax; William T Abraham; Jeffrey S Borer; Kenneth Dickstein; Jagmeet P Singh; Daniel Gras; Johannes Holzmeister; Josep Brugada; Frank Ruschitzka
Journal:  J Am Heart Assoc       Date:  2018-05-27       Impact factor: 5.501

4.  Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling.

Authors:  Neus Bellera; Ignasi Barba; Antonio Rodriguez-Sinovas; Eulalia Ferret; Miguel Angel Asín; M Teresa Gonzalez-Alujas; Jordi Pérez-Rodon; Marielle Esteves; Carla Fonseca; Nuria Toran; Bruno Garcia Del Blanco; Amadeo Pérez; David Garcia-Dorado
Journal:  J Am Heart Assoc       Date:  2014-09-19       Impact factor: 5.501

5.  Circulating metabolite profiles to predict response to cardiac resynchronization therapy.

Authors:  Xue Gong; Zhonghan Sun; Zheyong Huang; Qian Zhou; Ziqing Yu; Xueying Chen; Wenqi Shao; Yan Zheng; Yixiu Liang; Shengmei Qin; Yangang Su; Junbo Ge
Journal:  BMC Cardiovasc Disord       Date:  2020-04-16       Impact factor: 2.298

6.  Combination of Left Ventricular End-Diastolic Diameter and QRS Duration Strongly Predicts Good Response to and Prognosis of Cardiac Resynchronization Therapy.

Authors:  Zhinian Guo; Xiaoyan Liu; Xiaofeng Cheng; Chuan Liu; Ping Li; Yongming He; Rongsheng Rao; Chun Li; Yunlong Chen; Yong Zhang; Xiaoyu Luo; Jiang Wang
Journal:  Cardiol Res Pract       Date:  2020-01-17       Impact factor: 1.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.